Verosudil

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameVerosudil
Drug Alias Nameverosudil维舒地尔verosudilum维罗舒地尔AR-12286 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRhodopsin kinase inhibitors
TargetsRhodopsin kinase
Therapy Area/IndicationsGlaucoma, Open-AngleGlaucomaOcular Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAerie Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe New York Glaucoma InstituteAerie Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsGlaucoma, Open-AngleGlaucomaOcular Hypertension

Other Information

ATC CodeN/A
Related LinksKEGG